Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C32H44O8 |
Molecular Weight | 556.687 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1([C@H](O)C[C@@]2(C)[C@]3([H])CC=C4[C@@]([H])(C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C)[C@@](C)(O)C(=O)\C=C\C(C)(C)OC(C)=O
InChI
InChIKey=NDYMQXYDSVBNLL-MUYMLXPFSA-N
InChI=1S/C32H44O8/c1-17(33)40-27(2,3)13-12-23(36)32(9,39)25-21(35)15-29(6)22-11-10-18-19(14-20(34)26(38)28(18,4)5)31(22,8)24(37)16-30(25,29)7/h10,12-14,19,21-22,25,34-35,39H,11,15-16H2,1-9H3/b13-12+/t19-,21-,22+,25+,29+,30-,31+,32+/m1/s1
Molecular Formula | C32H44O8 |
Molecular Weight | 556.687 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 8 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Cucurbitacin E (CuE), a potent member of triterpenoid family isolated from plants, has been confirmed as an antitumor agent by inhibiting proliferation, migration, and metastasis in diverse cancer. Cucurbitacin E nhibits OS tumor growth and invasion through inhibiting the PI3K/Akt/mTOR signaling pathway. CuE can be considered to be a promising anticancer agent for OS. Cucurbitacin E exerts anti-inflammatory actions. It inhibited both COX enzymes with more selectivity toward COX-2. CuE has been reported to possess anti-inflammatory and anti-tumorigenic properties mediated by its action on the cellular cytoskeleton, on mitotic pathways as well as on cellular autophagy.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21871542 |
90.0 µM [IC50] | ||
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21871542 |
69.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21871542
Cucurbitacin E was intra-peritoneally administered to mice at the
dose of 30 and 60 mg/kg.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20110807
Cucurbitacin E at low concentrations (3-50 nmol/l) inhibited the growth of HL-60 cells, which was associated with G2/M cell-cycle arrest, decrease in the levels of cyclin-dependent kinase1, and increase in the levels of p21. Cucurbitacin E at high concentrations (1-10 mol/l) induced apoptosis of HL-60 cells and activation of caspase-3, caspase-8, and caspase-9
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:58:24 GMT 2023
by
admin
on
Sat Dec 16 06:58:24 GMT 2023
|
Record UNII |
V8A45XYI21
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
V8A45XYI21
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
106399
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
3944
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
DTXSID601030496
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
5281319
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
CUCURBITACIN E
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
242-325-2
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
521775
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | |||
|
m3874
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
18444-66-1
Created by
admin on Sat Dec 16 06:58:24 GMT 2023 , Edited by admin on Sat Dec 16 06:58:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |